← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2012Last known activity
Oct 27, 2021
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 4 trials)
Phase 4 (5 own, 0 via acquisition)
Indications
Studied for
Recent trials (10)
- NCT05124314Reponsible party - principal investigatorPhase 4Oct 27, 2021
- NCT05124314Lead sponsorPhase 4Oct 27, 2021
- NCT05124314Overall official - principal investigatorPhase 4Oct 27, 2021
- NCT04280874Study chairPhase 4Dec 10, 2018
- NCT04280874Reponsible party - principal investigatorPhase 4Dec 10, 2018
- NCT04280874Lead sponsorPhase 4Dec 10, 2018
- NCT01860183Lead sponsorPhase 4May 1, 2013
- NCT01510795Overall official - principal investigatorPhase 4Jan 1, 2012
- NCT01510795Lead sponsorPhase 4Jan 1, 2012
- NCT01510795Study directorPhase 4Jan 1, 2012
Details
- Last known activity
- Oct 27, 2021